IVUS-Guided versus Angiography-Guided PCI in Unprotected Left Main Coronary Disease
Luca Testa·Adrian P. Banning·Pablo Piñón-Esteban·Gianluca Campo·Bruno Garcia del Blanco·Manuel Pan·Tamara García-Camarero·Gennaro Sardella·Peter O’Kane·F Ribichini·Alfonso Ielasi·James Cockburn·Azfar G. Zaman·Francesco Bedogni·Wietze Lindeboom·Jan G.P. Tijssen·Ernest Spitzer·J M De La Torre Hernandez·Daniel A. Jones·J Greenwood·Irene Pescetelli·Iñigo Lozano·Jacopo Oreglia·Giovanni Luigi De Maria
Among patients with unprotected left main coronary artery disease, IVUS-guided PCI showed no additional benefit over angiography-guided PCI with respect to the incidence of stroke, myocardial infarction, any revascularization, or death from any cause at a median follow-up of 2.9 years. (Funded by Philips Image Guided Therapy Devices and Boston Scientific; OPTIMAL ClinicalTrials.gov number, NCT04111770.).